Loretta Swit, who played ‘Hot Lips' Houlihan on M*A*S*H, dies aged 87
Loretta Swit, who won two Emmy awards for playing Major Margaret Houlihan, the demanding head nurse of a behind-the-lines surgical unit during the Korean war on the pioneering hit TV series M*A*S*H, has died. She was 87.
Publicist Harlan Boll says Swit died on Friday at her home in New York City, likely from natural causes.
Swit and Alan Alda were the longest-serving cast members on M*A*S*H, the series based on Robert Altman's 1970 film, which was itself based on a novel by Richard Hooker, the pseudonym of H Richard Hornberger.
The CBS show aired for 11 years from 1972 to 1983, revolving around life at the 4077th Mobile Army Surgical hospital, which gave the show its name. The two-and-a-half-hour finale on 28 February 1983, lured over 100 million viewers, the most-watched episode of any scripted series ever.
Rolling Stone magazine put M*A*S*H at No 25 of the best TV shows of all time, while Time Out put it at No 34. It won the Impact Award at the 2009 TV Land annual awards. It won a Peabody Award in 1975 'for the depth of its humor and the manner in which comedy is used to lift the spirit and, as well, to offer a profound statement on the nature of war'.
In Altman's 1970 film, Houlihan was a one-dimensional character – a sex-crazed bimbo who earned the nickname 'Hot Lips'. Her intimate moments were broadcast to the entire camp after somebody planted a microphone under her bed.
Sally Kellerman played Houlihan in the movie version and Swit took it over for TV, eventually deepening and creating her into a much fuller character. The sexual appetite was played down and she wasn't even called Hot Lips in the later years.
The growing awareness of feminism in the 70s spurred Houlihan's transformation from caricature to real person, but a lot of the change was due to Swit's influence on the scriptwriters.
'Around the second or third year I decided to try to play her as a real person, in an intelligent fashion, even if it meant hurting the jokes,' Swit told Suzy Kalter, the author of The Complete Book of M*A*S*H.
'To oversimplify it, I took each traumatic change that happened in her life and kept it. I didn't go into the next episode as if it were a different character in a different play. She was a character in constant flux; she never stopped developing.'
Swit's other roles included films such as Race with the Devil and SOB and shows including The Love Boat. She also played Christine Cagney in the pilot movie of Cagney & Lacey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
33 minutes ago
- Daily Mail
Disney World fans threaten to BOYCOTT as theme park reveals closing date of beloved ride: 'Canceling my trip'
Disney World fans are threatening to boycott the theme park after it unveiled the first major details on its upcoming Cars land... and finally confirmed the closing date of a beloved ride. The Happiest Place on Earth announced last year that it would be getting rid of Tom Sawyer Island in Magic Kingdom's Frontierland to make way for a new Lightning McQueen-themed area. Now, the theme park has revealed when it will officially be shut down - and the news has left hoards of Disney fans across the globe outraged. Tom Sawyer Island, as well as the Liberty Square Riverboat ride, will have its final day of operation on July 6, 2025. That means guests only have a little more than a month left to enjoy the serene island inspired by the stories of Mark Twain. Immediately, Disney park-goers took to X, formerly Twitter, to share their heartbreak over the announcement, and some even admitted that they no longer wanted to visit the park. 'Canceling my trip in October and sadly, will never visit that park again,' one user announced. 'This is an abomination and a real disservice to all those who booked summer trips hoping to enjoy all this one more time,' added another. 'Talk about timing. Thankful we enjoyed it recently.' 'Never going back,' someone else wrote. 'I have a lot of happy memories there, and I'll keep them.' 'Huge mistake. Huge,' a fourth tweet read, while a fifth said, 'Largest downgrade.' 'Sorry but I'm not going to Disney World anymore. I'm staying at my home park, which is Disneyland in Anaheim, California,' a different user shared. 'I am heartbroken at the loss of Tom Sawyer island this is the WORST decision ever,' someone else penned. 'This is a travesty! Build new somewhere else. We want nostalgia,' urged another person. Disney shared new details about the upcoming changes coming to Magic Kingdom in a press release on Tuesday. The new Cars land will contain two dazzling attractions. One will 'be geared towards smaller guests and will be fun for the whole family,' while the second will 'invite you on a thrilling rally race through the mountains.' The company explained that the new area will be called Piston Peak National Park and described it as an 'awe-inspiring wilderness filled with towering trees, snowcapped mountains, breathtaking waterfalls, roaring rivers and impressive geysers.' The Cars land will contain two attractions. One will be 'fun for the whole family,' while the other will 'invite you on a thrilling race through the mountains.' Concept art for the land is seen 'While fictional, Piston Peak is inspired by the Rocky Mountain area and the history and iconic sights of the American Frontier and its national parks,' it added. 'Inside Piston Peak, guests will be able to see and explore the visitor lodge, Ranger HQ, trails, and more - all set within the Disney and Pixar Cars universe. 'To make sure these buildings fit naturally within the surrounding majestic landscapes, Imagineers are using a style of architecture called "Parkitecture," which was developed by the National Park Service to create structures that harmonize with the natural environment. 'Rugged mountains with dramatic peaks will be nestled along a calming waterway across from Grizzly Hall and soaring geysers from the famed Big Thunder Mountain Railroad will stretch into the trails of our off-road rally.' Disney also promised that 'imagineers are hard at work' bringing the 'first-ever land inspired by the Disney villains' to life, which will be located behind the Big Thunder Mountain ride in Magic Kingdom. The company explained in a press release on Tuesday that the new area will be called Piston Peak National Park. A concept art for one of the Cars rides is seen Disney also promised that 'Imagineers are hard at work' bringing the 'first-ever land inspired by the Disney villains' to life. Concept art for the villains land is seen Over in Hollywood Studios, a new Monsters Inc. land will replace Muppets Courtyard; The Muppet*Vision 3D ride will close on June 8, 2025 That land will feature two more new rides, dining, and shopping 'all on an incredibly twisted grand scale.' Tons of other new stuff are in the works at Disney World, including an Encanto river ride, an Indiana Jones attraction, and a Zootopia show at Animal Kingdom. But that means guests will have to say goodbye to DinoLand and the Dinosaur ride, which is slated to close in 2026. Over in Hollywood Studios, a new Monsters Inc. land will replace Muppets Courtyard; The Muppet*Vision 3D ride will close on June 8, 2025. The Monsters Inc. area is set to have a suspended rollercoaster that will put riders 'right in the middle of the monster action.'
Daily Mail
33 minutes ago
- Daily Mail
Armie Hammer reunites with ex-wife and kids for milestone... after scary cannibalism scandal
Armie Hammer had a rare reunion with his ex-wife Elizabeth Chambers to celebrate an important milestone with their eight-year-old son Ford. The 38-year-old actor and his 42-year-old ex Chambers share two children together, Ford and 10-year-old daughter Harper. The Social Network star and his entrepreneur/TV personality wife were married from 2010 until their split in 2020, with their divorce finalized in 2023, amid his cannibalism scandal. The exes have been co-parenting their children since the split, and they came together to celebrate Ford completing the second grade. Chambers shared a joyful snap of the exes and their kids, with Chambers sharing his second grade completion certificate. 'Happy 2nd Grade Step-Up Fordy Boy!' the doting mom said in the snap, with her son holding on to the family's dog. Armie was seen smiling in the snap with his arm around Harper, donning a black t-shirt, black pants and holding a black coat. Chambers donned a stylish black and white striped dress along with gold bracelets and gold earrings for the outing. Hammer shot to fame after playing the Winklevoss Twins in 2010's The Social Network, that was instrumental in launching his career. That rising career quickly came crashing down in 2021 when multiple accusations of sexual assault, rape and even cannibalism surfaced. While the LAPD launched an investigation, no charges were filed against the actor, who has admitted to consensual BDSM and emotional abuse, but denies all sexual assault and cannibalism charges, which stemmed from a woman named Courtney Vucekovich who alleged he said he wanted to cook and eat one of her ribs. Chambers recently promoted her upcoming show Toxic on The Today Show, where she admitted that things were great with her ex and children. 'They're amazing. We're amazing. I think we've never been stronger as a family,' Chambers said. 'This show touches on domestic violence, it touches on really unhealthy patterns. For me, I just experienced betrayal,' she said of her relationship with Hammer. 'But in that process, I really learned so much about patterns and how parenting, really it comes down to parenting,' Chambers added. 'It comes down to humanity and psychology and all of those interesting things,' she said, while admitting she's not a fan of the term 'co-parenting.' 'I don't love that word co-parenting, right? I think we're just parents and everyone is just parenting as well as they can with what they have,' Chambers said. 'Our family is, again, so strong and better than ever. But for me, divorce in itself is just trauma, Chambers admitted.
The Independent
33 minutes ago
- The Independent
Millions of doses of ‘pandemic-ending' HIV jab at risk over Trump's aid cuts
Professor Linda-Gail Bekker recalls having 'shivers' when she found out that not one single woman given a revolutionary new jab in her medical trial had caught HIV. She told a global Aids summit last year that she 'literally burst into tears.' Now, she tells The Independent, that emotion has turned into an 'acute sense of despair '. The funding to get lenacapavir – a twice-yearly preventative jab that has been described as the nearest thing we have to an HIV vaccine – out to at least two million people around the globe is in question amid the turmoil accompanying Donald Trump decision to slash US aid spending. Lenacapavir stops HIV from replicating meaning that, as long as someone is on the drug, they are almost totally protected from developing the virus if they are exposed to it. Prof Bekker's study found a 96 per cent reduction in HIV overall - but in the arm of the trial looking at women and adolescent girls, there were no infections at all. Global funders, led by Pepfar and the Global Fund, in December promised to secure enough doses of the jab to protect at least two million people over three years. Its manufacturer Gilead says it will sell these at no profit, though it has not made the cost of a dose public. Gilead has also signed agreements with six pharmaceutical companies in India, Pakistan, Egypt, and the US to allow them to make generic versions of the drug in order to increase supply and drive down the cost of the jab. A significant chunk of the money to fund the doses of lenacapavir was set to come from the US-led global Aids response programme, the US President's Emergency Plan for Aids Relief (Pepfar). But this funding, and the future of Pepfar itself, is now uncertain. 'In all of the excitement [of the trial results] we were thinking, well, what do you do with [the] doses? What's the best way to use it?' Prof Bekker says. 'Suddenly, that is very much up in the air'. The other main funding source, the Global Fund to Fight AIDS, Tuberculosis and Malaria has said that it still aims to fund the doses of lenacapavir. Speaking to The Independent, however, Global Fund executive director Peter Sands tempers this by saying the success of his organisation's funding round coming up later this year would, 'determine how much scope we have for this'. The US was the Global Fund's biggest donor. Sands says that while he would 'love to say' the Global Fund could fill the gap, this would be contingent on how much money is raised from governments and private donors. "Despite all the uncertainties both around Pepfar and our own future funding, we are still very keen to deliver on the ambition,' Sands says. But, more funding than they have currently been pledged will be needed to, 'realise the full potential of lenacapavir'. At the World Health Organisation (WHO)'s annual decision-making meeting which concluded late last month, the United Nations' Aids agency (UNAIDS) called for 'urgent action to avoid millions of avoidable HIV infections and Aids-related deaths,' saying this included, 'access to long-acting injectables for HIV prevention which are almost 100 per cent effective at preventing infections' – a nod to lenacapavir. 'A missed opportunity' Prof Bekker played a crucial role in trialling the jab in eight countries including her home country of South Africa, and she was on the brink of seeing that breakthrough rolled out – it could have been in people's arms by the end of this year. Long-acting jabs like lenacapavir are not only about protecting individuals, they are a crucial part of ending the Aids pandemic, Prof Bekker explains. 'A six-monthly injectable is as close as we can get at this moment to a vaccine,' Prof Bekker says. Just like with a vaccine, it can help keep whole populations safe by stopping vulnerable people from catching the virus and then potentially spreading the virus to more people. 'You finally have something that could actually bring us to a conclusion [of the Aids crisis]. 'It just feels like such a calamitous missed opportunity,' she says. Overcoming stigma A daily preventative medicine – a combination of two drugs known collectively as pre-exposure prophylaxis (PrEP) – is already available and is very effective. But people without reliable access to healthcare find it harder to maintain a regime that involves regular pills. Girls, young women and LGBT+ people in Southern Africa can also face questioning from family members if they have packets of daily pills in their homes which indicate they are sexually active, and it can put women in relationships at higher risk of domestic violence. A six-monthly jab on the other hand can be maintained more discreetly and with less user error. Offering lenacapavir to young women – among the hardest to reach with HIV prevention - when they book into prenatal care can also prevent them from passing the virus onto their children. 'That is a good use of money, right?' Prof Bekker says. 'You're saving two infections; one of them a lifelong infection in a child that will need antivirals for the next 70 to 75 years'. 'They are young people in front of us. We can introduce them to Republican Congressmen if needed'. A State Department spokesperson said: 'Pepfar continues to support lifesaving HIV testing, care and treatment, and prevention of mother to child transmission services approved by the Secretary of State. 'As directed by the Secretary of State all other Pepfar-funded services are being reviewed for assessment of programmatic efficiencies and consistency with United States foreign policy. Pepfar, like all assistance programmes, should be reduced over time as it achieves its mission.' Ending Aids Figures previously reported by The Independent suggest Trump's slashing of foreign aid has derailed the projected end of the Aids pandemic and could lead to four million extra deaths by 2030. The latest global figures show there were 1.3 million new HIV infections and roughly 630,00 people dying from Aids around the world in 2023. Regardless of the cuts, before any doses can be made available, the drug has to be approved by regulators. The US Food and Drug Administration (FDA)'s decision is understood to be on track to approve the preventative jab on 19 June, followed by other national medicines regulators and the WHO. Before the cuts, an FDA approval would have marked the moment it would be full steam ahead to roll lenacapavir out to the people who need it most. But those approvals won't count for much if the money to pay for the drug and get it out to the people who need it doesn't materialise, as Prof Bekker fears. 'It does feel like this thing that could help us end the epidemic sooner is suddenly receding in the chaos'.
